Loading...
Emyria Limited
EMD.AX•ASX
Healthcare
Medical - Healthcare Information Services
A$0.05
A$-0.00(-6.12%)
Emyria Limited (EMD.AX) Financial Performance & Income Statement Overview
Review Emyria Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
38.32%
↑ 38.32%
Operating Income Growth
3.02%
↑ 3.02%
Net Income Growth
-123.26%
↓ 123.26%
Operating Cash Flow Growth
-13.61%
↓ 13.61%
Operating Margin
-155.36%
↓ 155.36%
Gross Margin
-9.73%
↓ 9.73%
Net Profit Margin
-92.08%
↓ 92.08%
ROE
-55.89%
↓ 55.89%
ROIC
-67.51%
↓ 67.51%
Emyria Limited (EMD.AX) Income Statement & Financial Overview
Review Emyria Limited's (EMD.AX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $658199.00 | $1.11M | $1.09M | $860318.00 |
| Cost of Revenue | $727226.00 | $1.22M | $2.68M | $2.25M |
| Gross Profit | -$69027.00 | -$103389.00 | -$1.59M | -$1.39M |
| Gross Profit Ratio | -$0.10 | -$0.09 | -$1.46 | -$1.61 |
| R&D Expenses | $434743.00 | $1.10M | $1.05M | $852722.00 |
| SG&A Expenses | $593384.00 | $453208.00 | $1.09M | $854164.00 |
| Operating Expenses | $1.03M | $1.55M | $2.14M | $1.71M |
| Total Costs & Expenses | $1.76M | $2.77M | $4.82M | $3.95M |
| Interest Income | $0.00 | $20905.00 | $658.00 | $22847.00 |
| Interest Expense | $0.00 | $86663.00 | $166643.00 | $53382.00 |
| Depreciation & Amortization | $159080.00 | $130653.00 | $313757.00 | $181392.00 |
| EBITDA | -$413030.00 | $13271.00 | -$10.31M | -$3.01M |
| EBITDA Ratio | -$0.63 | $0.01 | -$9.47 | -$3.38 |
| Operating Income | -$1.10M | -$1.65M | -$3.73M | -$3.09M |
| Operating Income Ratio | -$1.67 | -$1.49 | -$3.42 | -$3.59 |
| Other Income/Expenses (Net) | -$1.33M | $992721.00 | -$7.07M | -$156600.00 |
| Income Before Tax | -$2.43M | -$661975.00 | -$10.79M | -$3.25M |
| Income Before Tax Ratio | -$3.69 | -$0.59 | -$9.91 | -$3.78 |
| Income Tax Expense | -$1.46M | $0.00 | $3.00 | -$2.09M |
| Net Income | -$968997.00 | -$661975.00 | -$10.79M | -$1.16M |
| Net Income Ratio | -$1.47 | -$0.59 | -$9.91 | -$1.35 |
| EPS | -$0.002 | -$0.002 | -$0.03 | -$0.004 |
| Diluted EPS | -$0.002 | -$0.002 | -$0.03 | -$0.004 |
| Weighted Avg Shares Outstanding | $421.30M | $381.76M | $332.82M | $310.63M |
| Weighted Avg Shares Outstanding (Diluted) | $421.30M | $385.12M | $332.82M | $310.63M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan